ArticleCureus2025
The Influence of Social Media on Melanoma Prevention: A Retrospective Analysis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pre-Post Evaluation of a Sun Safety Social Media Campaign for Young Adults to Reduce Skin Cancer Risk.JMIR dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The widespread use of social media has introduced novel opportunities for public health communication, particularly among adolescents and young adults. In dermatology, these platforms are increasingly employed to disseminate information on skin cancer prevention and early detection. Given the rising incidence of melanoma in younger populations, social media represents a strategic tool to enhance awareness, promote protective behaviors, and support early screening initiatives. Aim This study aims to explore the main referral sources for dermoscopic examination in patients with multiple melanocytic nevi (MMN) and to assess the role of social media across different demographic groups. Methods A retrospective study was conducted on 144 patients with >10 melanocytic nevi undergoing dermoscopy for the first time at a private dermatology clinic in Tirana, Albania, between 2023 and 2024, selected from a total of 1,103 screened patients. Dermoscopic examinations were performed using the FotoFinder Vexia Medicam 1000s, and images were evaluated by an experienced dermatologist based on international diagnostic criteria. Statistical analyses included Student's t-test, Chi-square test, and one-way ANOVA; p < 0.05 was considered statistically significant. Results Among 1,103 patients, 144 met the inclusion criteria. The cohort had a mean age of 30.49 ± 10.34 years and was 68% female. The leading referral source was social media exposure (31.7%), followed by dermatologist referrals (22.5%) and personal concern about mole changes (16.9%). Older patients were more often referred by dermatologists (35.56 ± 12.52 years; p = 0.001) or presented due to personal concerns (34.50 ± 9.93 years; p = 0.036), whereas younger patients more frequently sought dermoscopy due to social media exposure (26.53 ± 8.01 years; p = 0.001). Men were more likely to be referred by dermatologists (37% vs. 16.5%; p = 0.010), while women were more likely to seek dermoscopy based on self-observed mole changes (21.6% vs. 6.5%; p = 0.030). Conclusion Social media plays a significant role in motivating younger individuals to seek dermoscopic evaluation, while older adults are more influenced by clinical referrals or personal concern. The observed age and gender differences in referral pathways underscore the importance of targeted digital health strategies to promote early melanoma detection. However, as this study was a single-center retrospective analysis with a limited sample size, the findings should be interpreted cautiously. Larger, prospective studies are needed to confirm these results and assess their broader public health implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.